|
|
 |
|
¡¡ |
|
¡¡ |
|
|
|
¡¡ |
HOME > ÇÐȸ°£Ç๰ >
¿ë¾î»çÀü |
|
Á¦¸ñ |
A STUDY ON THE CHANGE OF SERUM ANTI-PGL-I ANTIBODY ACCORDING TO MULTIDRURG THERAPY IN NEW AND RELAPSED MULTIBACILLARY LEPROSY PATIENTS |
|
|
|
|
ÀúÀÚ |
Sung Jun Choi |
¼Ò¼Ó |
Institute for Leprosy Research, KLCA |
|
|
³âµµ |
1988 |
±Ç |
21 |
|
|
È£ |
1 |
¹øÈ£ |
|
|
|
½ÃÀÛÆäÀÌÁö |
35 |
³¡ÆäÀÌÁö |
42 |
|
|
÷ºÎ |
|
|
|
¿ä¾à |
With ELISA test using ND-O-BSA as antigen, anti-PGL-I IgM antibody titers were followed up serially for 6 months after initiation of multidrug therapy in 14 multibacillary new patients, 9 relapsed patients, and 118 normal healthy control group and the following results were obtained. 1. The average anti-PGI-I IgM antibody titer of the new cases was 1.14¡¾0.58 (positive rate: 93%), and that of the relapsed cases was 0.82¡¾0.69 (positive rate : 78%), and their values were significantly higher (P<0.001) than that of normal control group, 0.035¡¾0.072 (positive rate: 3%). 2. The average antibody titer in patients whose BI were 6+ was 1.30, and in each patients group with BI 5 ,4 , 3 ,2 , that was 0.92, 0.53, 0.79, and 0.51. Like this the more the bacterial index increases, the more antibody titers increased in general. 3. Of 7 ENL cases, there were no significant changes of antibody titers in 4 patients, but in 3 cases antibody titers decreased significantly after development of ENL. 4. All cases except 2 cases showed no decreasing tendency of antibody titers during the first 6 months after initiation of multidrug therapy. |
|
|
³»¿ë |
|
 | |
¡¡ |
|
|
|
|
|
|
|
|